PIII
The table below shows P3 Health Partners's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$91.24M | -$110.13M | -$76.03M | -$126.02M | -$1.59M | -$24.60M |
| Capital expenditure | - | $0.00 | $1.83M | $2.23M | $3.29M | $2.93M |
| Investing cash flow | $129.00K | $14.53M | -$1.83M | -$7.73M | -$316.25M | -$3.17M |
| Dividends paid | - | - | - | - | - |
P3 Health Partners reported operating cash flow of -$91.24M for fiscal year 2025. That is up 17.2% from -$110.13M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$28.29M (FY 2019) to -$91.24M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $72.81M | $98.77M | $100.33M | $11.38M | $317.76M | $34.76M |